GSDMC and neoplasm: The results conclusively demonstrate a substantial influx of lymphoid anti‐tumor immune cells, such as CD4, CD8 T cells, and NK cells upon Gsdmc inhibition, accompanied by a reduction in M2‐type TAMs (Figure S8F,G, Supporting Information).